75
Participants
Start Date
November 20, 2024
Primary Completion Date
February 29, 2028
Study Completion Date
August 31, 2028
Lenacapavir
Tablets administered orally without regard to food
BIC/LEN FDC
Tablets administered orally without regard to food
RECRUITING
Perinatal HIV Research Unit, Johannesburg
RECRUITING
Wits RHI Shandukani Research Centre CRS, Johannesburg
RECRUITING
Nkanyezi VIDA Research Unit, Johannesburg
RECRUITING
Durban International Clinical Research Site, Enhancing Care Foundation, Durban
RECRUITING
Clinical Research Institute of South Africa (CRISA), KwaDukuza
ACTIVE_NOT_RECRUITING
FAMCRU Ukwanda School for Rural Health, Cape Town
RECRUITING
Be Part Yoluntu, Cape Town
RECRUITING
Children's National Hospital, Washington D.C.
RECRUITING
ASST FBF Sacco Ospedale Sacco, Milan
RECRUITING
Hospital General Universitario Gregorio Marano, Madrid
RECRUITING
Hospital Universitario 12 De Octubre, Madrid
RECRUITING
Hospital Universitario La Paz, Madrid
RECRUITING
Grady Ponce de Leon Center, Atlanta
RECRUITING
University of South Florida, Tampa
RECRUITING
Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
Helios Salud S.A, Buenos Aires
RECRUITING
IRCCS Ospedale Pediatrico Bambino Gesu, UOS Infezioni Complesse e Perinatali, Roma
RECRUITING
The Aurum Institute: Pretoria Clinical Research Centre, Pretoria
ACTIVE_NOT_RECRUITING
Setshaba Research Centre, Soshanguve
Lead Sponsor
Gilead Sciences
INDUSTRY